Glucose and the injured brain-monitored in the neurointensive care unit

Frontiers in Neurology

Volumn 5 JUN, Issue , 2014, Pages

  Rostami, Elham ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Glucose; Hyperglycemia; Intensive insulin therapy; Microdialysis; Neurocritical care; Neuromonitoring; Subarachnoid hemorrhage; Traumatic brain injury

Indexed keywords

GLUCOSE;

BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CATHETER; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE UNIT; MICRODIALYSIS; MONITORING; OUTCOME ASSESSMENT; REVIEW; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

EID: 84904422750     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00091     Document Type: Review

References (116)

1. Elf K, Nilsson P, Enblad P. Outcome after traumatic brain injury improved by an organized secondary insult program and standardized neurointensive care. Crit Care Med (2002) 30:2129-34. doi:10.1097/00003246-200209000-00029
2. Patel HC, Menon DK, Tebbs S, Hawker R, Hutchinson PJ, Kirkpatrick PJ. Specialist neurocritical care and outcome from head injury. Intensive Care Med (2002) 28:547-53. doi:10.1007/s00134-002-1235-4
3. Clayton TJ, Nelson RJ, Manara AR. Reduction in mortality from severe head injury following introduction of a protocol for intensive care management. Br J Anaesth (2004) 93:761-7. doi:10.1093/bja/aeh249
4. Fakhry SM, Trask AL, Waller MA, Watts DD. Management of brain-injured patients by an evidence-based medicine protocol improves outcomes and decreases hospital charges. J Trauma (2004) 56:492-9; discussion 499-500. doi:10.1097/01.TA.0000115650.07193.66
5. Siesjo BK, Siesjo P. Mechanisms of secondary brain injury. Eur J Anaesthesiol (1996) 13:247-68. doi:10.1097/00003643-199605000-00004
6. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth (2007) 99:4-9. doi:10.1093/bja/aem131
7. Bellander BM, Cantais E, Enblad P, Hutchinson P, Nordstrom CH, Robertson C, et al. Consensus meeting on microdialysis in neurointensive care. Intensive Care Med (2004) 30:2166-9. doi:10.1007/s00134-004-2461-8
8. Ungerstedt U, Rostami E. Microdialysis in neurointensive care. Curr Pharm Des (2004) 10:2145-52. doi:10.2174/1381612043384105
9. Hillered L, Persson L, Nilsson P, Ronne-Engstrom E, Enblad P. Continuous monitoring of cerebral metabolism in traumatic brain injury: a focus on cerebral microdialysis. Curr Opin Crit Care (2006) 12:112-8. doi:10.1097/01.ccx.0000216576.11439.df
10. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 345:1359-67. doi:10.1056/NEJMoa011300
11. Van Den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 354:449-61. doi:10.1056/NEJMoa052521
12. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med (2009) 360:1283-97. doi:10.1056/NEJMoa0810625
13. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: pathophysiology. J Neurosurg (1992) 77:169-84. doi:10.3171/jns.1992.77.2.0169
14. Pellerin L. Brain energetics (thought needs food). Curr Opin Clin Nutr Metab Care (2008) 11:701-5. doi:10.1097/MCO.0b013e328312c368
15. Erecinska M, Silver IA. ATP and brain function. J Cereb Blood Flow Metab (1989) 9:2-19. doi:10.1038/jcbfm.1989.2
16. Siesjo BK. Mechanisms of ischemic brain damage. Crit Care Med (1988) 16:954-63. doi:10.1097/00003246-198810000-00006
17. Lowry OH, Passonneau JV. The relationships between substrates and enzymes of glycolysis in brain. J Biol Chem (1964) 239:31-42.
18. Gatfield PD, Lowry OH, Schulz DW, Passonneau JV. Regional energy reserves in mouse brain and changes with ischaemia and anaesthesia. J Neurochem (1966) 13:185-95. doi:10.1111/j.1471-4159.1966.tb07512.x
19. Smith ML, von Hanwehr R, Siesjo BK. Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats. J Cereb Blood Flow Metab (1986) 6:574-83. doi:10.1038/jcbfm.1986.104
20. Nedergaard M, Goldman SA, Desai S, Pulsinelli WA. Acid-induced death in neurons and glia. J Neurosci (1991) 11:2489-97.
21. Berthet C, Lei H, Thevenet J, Gruetter R, Magistretti PJ, Hirt L. Neuroprotective role of lactate after cerebral ischemia. J Cereb Blood Flow Metab (2009) 29:1780-9. doi:10.1038/jcbfm.2009.97
22. Myers RE, Yamaguchi S. Nervous system effects of cardiac arrest in monkeys. Preservation of vision. Arch Neurol (1977) 34:65-74. doi:10.1001/archneur.1977.00500140019003
23. Katsura K, Kristian T, Smith ML, Siesjo BK. Acidosis induced by hypercapnia exaggerates ischemic brain damage. J Cereb Blood Flow Metab (1994) 14:243-50. doi:10.1038/jcbfm.1994.31
24. Gisselsson L, Smith ML, Siesjo BK. Hyperglycemia and focal brain ischemia. J Cereb Blood Flow Metab (1999) 19:288-97. doi:10.1097/00004647-199903000-00007
25. Pelligrino DA, Lamanna JC, Duckrow RB, Bryan RM Jr, Harik SI. Hyperglycemia and blood-brain barrier glucose transport. J Cereb Blood Flow Metab (1992) 12:887-99. doi:10.1038/jcbfm.1992.126
26. Ungerstedt U, Pycock C. Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss (1974) 30:44-55.
27. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med (1991) 230:365-73. doi:10.1111/j.1365-2796.1991.tb00459.x
28. Reinstrup P, Stahl N, Mellergard P, Uski T, Ungerstedt U, Nordstrom CH. Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery (2000) 47:701-9; discussion 709-10. doi:10.1227/00006123-200009000-00035
29. Hacke W, Schwab S, Horn M, Spranger M, de Georgia M, von Kummer R. "Malignant" middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol (1996) 53:309-15. doi:10.1001/archneur.1996.00550040037012
30. Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke (2001) 32:2117-23. doi:10.1161/hs0901.095719
31. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet (1999) 353:376-7. doi:10.1016/S0140-6736(05)74948-5
32. Lanier WL, Stangland KJ, Scheithauer BW, Milde JH, Michenfelder JD. The effects of dextrose infusion and head position on neurologic outcome after complete cerebral ischemia in primates: examination of a model. Anesthesiology (1987) 66:39-48. doi:10.1097/00000542-198701000-00008
33. Nakakimura K, Fleischer JE, Drummond JC, Scheller MS, Zornow MH, Grafe MR, et al. Glucose administration before cardiac arrest worsens neurologic outcome in cats. Anesthesiology (1990) 72:1005-11. doi:10.1097/00000542-199006000-00010
34. Natale JE, Stante SM, D'Alecy LG. Elevated brain lactate accumulation and increased neurologic deficit are associated with modest hyperglycemia in global brain ischemia. Resuscitation (1990) 19:271-89. doi:10.1016/0300-9572(90)90107-P
35. Palmon SC, Sieber FE, Brown PR, Koehler RC, Eleff SM, Traystman RJ. Poor hemodynamic and metabolic recovery after global incomplete cerebral ischemia associated with short-term diabetes in dogs. J Cereb Blood Flow Metab (1995) 15:673-80. doi:10.1038/jcbfm.1995.83
36. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology (1982) 32:1239-46. doi:10.1212/WNL.32.11.1239
37. Warner DS, Todd MM, Dexter F, Ludwig P, McAllister AM. Temporal thresholds for hyperglycemia-augmented ischemic brain damage in rats. Stroke (1995) 26:655-60. doi:10.1161/01.STR.26.4.655
38. MacDougall NJ, Muir KW. Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis. J Cereb Blood Flow Metab (2011) 31:807-18. doi:10.1038/jcbfm.2010.210
39. Candelise L, Landi G, Orazio EN, Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol (1985) 42:661-3. doi:10.1001/archneur.1985.04060070051014
40. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in acute stroke treatment (TOAST) investigators. Neurology (1999) 52:280-4. doi:10.1212/WNL.52.2.280
41. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke (2001) 32:2426-32. doi:10.1161/hs1001.096194
42. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke (2003) 34:2208-14. doi:10.1161/01.STR.0000085087.41330.FF
43. Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, et al. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke (2008) 39:1751-8. doi:10.1161/STROKEAHA.107.503334
44. Fuentes B, Castillo J, San Jose B, Leira R, Serena J, Vivancos J, et al. The prognostic value of capillary glucose levels in acute stroke: the glycemia in acute stroke (GLIAS) study. Stroke (2009) 40:562-8. doi:10.1161/STROKEAHA.108.519926
45. Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol (2010) 6:145-55. doi:10.1038/nrneurol.2009.231
46. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg (1995) 82:262-8. doi:10.3171/jns.1995.82.2.0262
47. Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis (2006) 22:116-22. doi:10.1159/000093239
48. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol (2007) 6:397-406. doi:10.1016/S1474-4422(07)70080-7
49. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke (2008) 39:384-9. doi:10.1161/STROKEAHA.107.493544
50. Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR. Glucose regulation in acute stroke patients (GRASP) trial: a randomized pilot trial. Stroke (2009) 40:3804-9. doi:10.1161/STROKEAHA.109.561498
51. Kreisel SH, Berschin UM, Hammes HP, Leweling H, Bertsch T, Hennerici MG, et al. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis (2009) 27:167-75. doi:10.1159/000185608
52. McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol (2010) 67:570-8. doi:10.1002/ana.21983
53. Staszewski J, Brodacki B, Kotowicz J, Stepien A. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. J Stroke Cerebrovasc Dis (2011) 20:150-4. doi:10.1016/j.jstrokecerebrovasdis.2009.11.013
54. Rosso C, Corvol JC, Pires C, Crozier S, Attal Y, Jacqueminet S, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke (2012) 43:2343-9. doi:10.1161/STROKEAHA.112.657122
55. Dohmen C, Bosche B, Graf R, Reithmeier T, Ernestus RI, Brinker G, et al. Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction. Stroke (2007) 38:56-61. doi:10.1161/01.STR.0000251642.18522.b6
56. Schneweis S, Grond M, Staub F, Brinker G, Neveling M, Dohmen C, et al. Predictive value of neurochemical monitoring in large middle cerebral artery infarction. Stroke (2001) 32:1863-7. doi:10.1161/01.STR.32.8.1863
57. Bosche B, Dohmen C, Graf R, Neveling M, Staub F, Kracht L, et al. Extracellular concentrations of non-transmitter amino acids in peri-infarct tissue of patients predict malignant middle cerebral artery infarction. Stroke (2003) 34:2908-13. doi:10.1161/01.STR.0000100158.51986.EB
58. Dohmen C, Bosche B, Graf R, Staub F, Kracht L, Sobesky J, et al. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke (2003) 34:2152-8. doi:10.1161/01.STR.0000083624.74929.32
59. Heiss WD, Dohmen C, Sobesky J, Kracht L, Bosche B, Staub F, et al. Identification of malignant brain edema after hemispheric stroke by PET-imaging and microdialysis. Acta Neurochir Suppl (2003) 86:237-40.
60. Berger C, Kiening K, Schwab S. Neurochemical monitoring of therapeutic effects in large human MCA infarction. Neurocrit Care (2008) 9:352-6. doi:10.1007/s12028-008-9093-8
61. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol (2003) 2:43-53. doi:10.1016/S1474-4422(03)00266-7
62. Sarti C, Tuomilehto J, Salomaa V, Sivenius J, Kaarsalo E, Narva EV, et al. Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke (1991) 22:848-53. doi:10.1161/01.STR.22.7.848
63. Hop JW, Rinkel GJ, Algra A, Van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 28:660-4. doi:10.1161/01.STR.28.3.660
64. Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry (2000) 68:337-41. doi:10.1136/jnnp.68.3.337
65. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke (2004) 35:1862-6. doi:10.1161/01.STR.0000133132.76983.8e
66. Schmidt JM, Wartenberg KE, Fernandez A, Claassen J, Rincon F, Ostapkovich ND, et al. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg (2008) 109:1052-9. doi:10.3171/JNS.2008.109.12.1052
67. Persson L, Enblad P. Neurointensive care of aneurysmal SAH. Acta Neurochir Suppl (1999) 72:73-80.
68. Persson L, Valtysson J, Enblad P, Warme PE, Cesarini K, Lewen A, et al. Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg (1996) 84:606-16. doi:10.3171/jns.1996.84.4.0606
69. Schulz MK, Wang LP, Tange M, Bjerre P. Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg (2000) 93:808-14. doi:10.3171/jns.2000.93.5.0808
70. Helbok R, Madineni RC, Schmidt MJ, Kurtz P, Fernandez L, Ko SB, et al. Intracerebral monitoring of silent infarcts after subarachnoid hemorrhage. Neurocrit Care (2011) 14:162-7. doi:10.1007/s12028-010-9472-9
71. Schmidt JM, Ko SB, Helbok R, Kurtz P, Stuart RM, Presciutti M, et al. Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage. Stroke (2011) 42:1351-6. doi:10.1161/STROKEAHA.110.596874
72. Janjua N, Mayer SA. Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care (2003) 9:113-9. doi:10.1097/00075198-200304000-00006
73. Hanggi D. Monitoring and detection of vasospasm II: EEG and invasive monitoring. Neurocrit Care (2011) 15:318-23. doi:10.1007/s12028-011-9583-y
74. Unterberg AW, Sakowitz OW, Sarrafzadeh AS, Benndorf G, Lanksch WR. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 94:740-9. doi:10.3171/jns.2001.94.5.0740
75. Sarrafzadeh AS, Sakowitz OW, Kiening KL, Benndorf G, Lanksch WR, Unterberg AW. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit Care Med (2002) 30:1062-70. doi:10.1097/00003246-200205000-00018
76. Nilsson OG, Brandt L, Ungerstedt U, Saveland H. Bedside detection of brain ischemia using intracerebral microdialysis: subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery (1999) 45:1176-84; discussion 1184-5. doi:10.1097/00006123-199911000-00032
77. Zetterling M, Hillered L, Enblad P, Karlsson T, Ronne-Engstrom E. Relation between brain interstitial and systemic glucose concentrations after subarachnoid hemorrhage. J Neurosurg (2011) 115:66-74. doi:10.3171/2011.3.JNS10899
78. Dorhout Mees SM, Van Dijk GW, Algra A, Kempink DR, Rinkel GJ. Glucose levels and outcome after subarachnoid hemorrhage. Neurology (2003) 61:1132-3. doi:10.1212/01.WNL.0000090466.68866.02
79. Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med (2005) 33:1603-9; quiz 1623. doi:10.1097/01.CCM.0000168054.60538.2B
80. Lanzino G. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg (2005) 102:974-5; discussion 975-6. doi:10.3171/jns.2005.102.6.0974
81. Frontera JA, Fernandez A, Claassen J, Schmidt M, Schumacher HC, Wartenberg K, et al. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke (2006) 37:199-203. doi:10.1161/01.STR.0000194960.73883.0f
82. Kruyt ND, Roos YW, Dorhout Mees SM, Van Den Bergh WM, Algra A, Rinkel GJ, et al. High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2008) 79:1382-5. doi:10.1136/jnnp.2007.142034
83. Kruyt ND, Biessels GJ, de Haan RJ, Vermeulen M, Rinkel GJ, Coert B, et al. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke (2009) 40:e424-30. doi:10.1161/STROKEAHA.108.529974
84. Hanafy KA, Morgan Stuart R, Fernandez L, Schmidt JM, Claassen J, Lee K, et al. Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage. J Clin Neurosci (2010) 17:22-5. doi:10.1016/j.jocn.2009.09.003
85. McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg (2007) 107:1080-5. doi:10.3171/JNS-07/12/1080
86. Kruyt ND, Biessels GJ, Devries JH, Luitse MJ, Vermeulen M, Rinkel GJ, et al. Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome. J Cereb Blood Flow Metab (2010) 30:1577-87. doi:10.1038/jcbfm.2010.102
87. Bell DA, Strong AJ. Glucose/insulin infusions in the treatment of subarachnoid haemorrhage: a feasibility study. Br J Neurosurg (2005) 19:21-4. doi:10.1080/02688690500089423
88. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol (2007) 19:156-60. doi:10.1097/ANA.0b013e3180338e69
89. Latorre JG, Chou SH, Nogueira RG, Singhal AB, Carter BS, Ogilvy CS, et al. Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke (2009) 40:1644-52. doi:10.1161/STROKEAHA.108.535534
90. Schlenk F, Vajkoczy P, Sarrafzadeh A. Inpatient hyperglycemia following aneurysmal subarachnoid hemorrhage: relation to cerebral metabolism and outcome. Neurocrit Care (2009) 11:56-63. doi:10.1007/s12028-009-9222-z
91. Thiele RH, Pouratian N, Zuo Z, Scalzo DC, Dobbs HA, Dumont AS, et al. Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology (2009) 110:603-10. doi:10.1097/ALN.0b013e318198006a
92. Naidech AM, Levasseur K, Liebling S, Garg RK, Shapiro M, Ault ML, et al. Moderate hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage. Neurocrit Care (2010) 12:181-7. doi:10.1007/s12028-009-9311-z
93. Schlenk F, Graetz D, Nagel A, Schmidt M, Sarrafzadeh AS. Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage. Crit Care (2008) 12:R9. doi:10.1186/cc6776
94. Schmidt JM, Claassen J, Ko SB, Lantigua H, Presciutti M, Lee K, et al. Nutritional support and brain tissue glucose metabolism in poor-grade SAH: a retrospective observational study. Crit Care (2012) 16:R15. doi:10.1186/cc11160
95. Ghajar J. Traumatic brain injury. Lancet (2000) 356:923-9. doi:10.1016/S0140-6736(00)02689-1
96. Morganti-Kossmann MC, Rancan M, Otto VI, Stahel PF, Kossmann T. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock (2001) 16:165-77. doi:10.1097/00024382-200116030-00001
97. Hutchinson PJ. Microdialysis in traumatic brain injury - methodology and pathophysiology. Acta Neurochir Suppl (2005) 95:441-5. doi:10.1007/3-211-32318-X_91
98. Andersen BJ, Marmarou A. Post-traumatic selective stimulation of glycolysis. Brain Res (1992) 585:184-9. doi:10.1016/0006-8993(92)91205-S
99. Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA, et al. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg (1997) 86:241-51. doi:10.3171/jns.1997.86.2.0241
100. Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 36:3233-8. doi:10.1097/CCM.0b013e31818f4026
101. Goodman JC, Valadka AB, Gopinath SP, Uzura M, Robertson CS. Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis. Crit Care Med (1999) 27:1965-73. doi:10.1097/00003246-199909000-00041
102. Vespa PM, McArthur D, O'Phelan K, Glenn T, Etchepare M, Kelly D, et al. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab (2003) 23:865-77. doi:10.1097/01.WCB.0000076701.45782.EF
103. Diaz-Parejo P, Stahl N, Xu W, Reinstrup P, Ungerstedt U, Nordstrom CH. Cerebral energy metabolism during transient hyperglycemia in patients with severe brain trauma. Intensive Care Med (2003) 29:544-50. doi:10.1007/s00134-003-1669-3
104. Timofeev I, Carpenter KL, Nortje J, Al-Rawi PG, O'Connell MT, Czosnyka M, et al. Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain (2011) 134:484-94. doi:10.1093/brain/awq353
105. Magnoni S, Tedesco C, Carbonara M, Pluderi M, Colombo A, Stocchetti N. Relationship between systemic glucose and cerebral glucose is preserved in patients with severe traumatic brain injury, but glucose delivery to the brain may become limited when oxidative metabolism is impaired: implications for glycemic control. Crit Care Med (2012) 40:1785-91. doi:10.1097/CCM.0b013e318246bd45
106. Rostami E, Bellander BM. Monitoring of glucose in brain, adipose tissue, and peripheral blood in patients with traumatic brain injury: a microdialysis study. J Diabetes Sci Technol (2011) 5:596-604. doi:10.1177/193229681100500314
107. Young B, Ott L, Dempsey R, Haack D, Tibbs P. Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Ann Surg (1989) 210:466-72; discussion 472-3. doi:10.1097/00000658-198910000-00007
108. Lam AM, Winn HR, Cullen BF, Sundling N. Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg (1991) 75:545-51. doi:10.3171/jns.1991.75.4.0545
109. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery (2000) 46:335-42; discussion 342-3. doi:10.1097/00006123-200002000-00015
110. Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma (2005) 58:47-50. doi:10.1097/01.TA.0000135158.42242.B1
111. Salim A, Hadjizacharia P, Dubose J, Brown C, Inaba K, Chan LS, et al. Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg (2009) 75:25-9.
112. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergsneider M, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med (2006) 34:850-6. doi:10.1097/01.CCM.0000201875.12245.6F
113. Meier R, Bechir M, Ludwig S, Sommerfeld J, Keel M, Steiger P, et al. Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury. Crit Care (2008) 12:R98. doi:10.1186/cc6974
114. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V, et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care (2008) 9:159-66. doi:10.1007/s12028-008-9084-9
115. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med (2008) 36:3190-7. doi:10.1097/CCM.0b013e31818f21aa
116. Marion DW. Optimum serum glucose levels for patients with severe traumatic brain injury. F1000 Med Rep (2009) 1:42. doi:10.3410/M1-42